BrainsWay Ltd. (BRSYF)
USD 4.27
(0.0%)
USD 4.27
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 239 Thousand USD | -5.91% |
| 2022 | 254 Thousand USD | 0.0% |
| 2021 | 254 Thousand USD | 4.53% |
| 2020 | 243 Thousand USD | -63.35% |
| 2019 | 663 Thousand USD | -68.17% |
| 2018 | 2.08 Million USD | -23.62% |
| 2017 | 2.72 Million USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 FY | 239 Thousand USD | -5.91% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q4 | 239 Thousand USD | 0.0% |
| 2022 FY | 254 Thousand USD | 0.0% |
| 2022 Q4 | 254 Thousand USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | 254 Thousand USD | 4.53% |
| 2021 Q4 | 254 Thousand USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 243 Thousand USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | 243 Thousand USD | -63.35% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q1 | 1.73 Million USD | -16.61% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q4 | 663 Thousand USD | 0.0% |
| 2019 FY | 663 Thousand USD | -68.17% |
| 2018 Q3 | 2.43 Million USD | -12.52% |
| 2018 Q4 | 2.08 Million USD | -14.32% |
| 2018 Q2 | 2.77 Million USD | 0.94% |
| 2018 Q1 | 2.75 Million USD | 0.95% |
| 2018 FY | 2.08 Million USD | -23.62% |
| 2017 Q4 | 2.72 Million USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | 2.72 Million USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Avitar, Inc. | 3.89 Million USD | 93.866% |
| BioElectronics Corporation | 12.52 Million USD | 98.093% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 161 Thousand USD | -48.447% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -105.939% |
| Polarean Imaging plc | 74.84 Thousand USD | -219.322% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 46.828% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.923% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 98.733% |
| Össur hf. | 311.8 Million USD | 99.923% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 61.327% |
| Escalon Medical Corp. | 279.4 Thousand USD | 14.461% |
| Aurora Spine Corporation | 1.59 Million USD | 84.986% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 98.569% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.971% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -9.829% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -447.211% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 59.492% |
| Nanomix Corporation | 10.11 Million USD | 97.636% |
| Theraclion SA | 1.95 Million EUR | 87.748% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 21.536% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -59.333% |
| Lombard Medical, Inc. | 28.02 Million USD | 99.147% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.732% |
| Vycor Medical, Inc. | 243.28 Thousand USD | 1.762% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -67.921% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 51.423% |
| VMS Rehab Systems, Inc. | 106.45 USD | -224418.553% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 53.229% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 55.098% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 70.274% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 25.869% |
| Urologix, Inc. | 4.58 Million USD | 94.788% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 44.449% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 91.422% |
| SS Innovations International, Inc. | 1.91 Million USD | 87.49% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.989% |
| NIOX Group Plc | 500 Thousand USD | 52.2% |
| Fuse Medical, Inc. | 200 Thousand USD | -19.5% |
| Broncus Holding Corporation | 1.22 Million USD | 80.474% |
| Brain Scientific Inc. | 7378.00 USD | -3139.36% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -47.655% |
| Health Logic Interactive Inc. | - USD | -Infinity% |